Pfizer Inc. (PFE) announced on Wednesday the divestment of 700 million shares in Haleon Plc (HLN), a prominent British multinational in the consumer healthcare sector. These shares were sold at a price of 357 pence each, roughly equivalent to $4.36 per share. This transaction is anticipated to generate approximately 2.50 billion pounds, or around $3.05 billion.
Following this sale, Pfizer's ownership stake in Haleon will decrease from about 15% to approximately 7.3%. The entirety of the net proceeds from this offering will be directed to Pfizer; Haleon is neither selling nor issuing any of its shares in this transaction. The settlement for this offering is scheduled to be completed on January 17.
The material has been provided by InstaForex Company - www.instaforex.com
Following this sale, Pfizer's ownership stake in Haleon will decrease from about 15% to approximately 7.3%. The entirety of the net proceeds from this offering will be directed to Pfizer; Haleon is neither selling nor issuing any of its shares in this transaction. The settlement for this offering is scheduled to be completed on January 17.
The material has been provided by InstaForex Company - www.instaforex.com